Clinical Trial

Stem Cells for Erectile Dysfunction Post RALP

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a phase 1/2 single center, pilot study to assess safety and efficacy of allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) and to evaluate the timing and combination effects of active treatment versus placebo in promoting the recovery of erectile function in patients undergoing radical retropubic prostatectomy (RALP) of localized prostate cancer.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-11
Trial Details
NCT Number NCT07048314
Lead Sponsor The Methodist Hospital Research Institute
Conditions Erectile Dysfunction, Prostate Cancer
Enrollment 40 participants
Start Date 2026-07-07
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-10